---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-131872"
form_type: "8-K"
ticker: "ASMB"
cik: "0001426800"
company_name: "ASSEMBLY BIOSCIENCES, INC."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:21:26.507997+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Assembly Biosciences adopts 2026 bonus plan; raises CEO bonus target to 65%

## Summary
- Compensation Committee approved 2026 Corporate Bonus Plan effective Jan 1, 2026 with corporate and individual performance objectives.
- CEO Jason Okazaki's bonus target increased from 60% to 65% of base salary via Amendment No. 1 to employment agreement.
- Bonus targets range: CEO up to 75%, other executives 30-55%, non-executives up to 28% of base salary.
- Bonuses range from 0 to 1.5 times target; payment expected in Q1 of following year, no later than March 15.

## SEC filing metadata
- accession: 0001193125-26-131872
- form_type: 8-K
- ticker: ASMB
- cik: 0001426800
- company_name: ASSEMBLY BIOSCIENCES, INC.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1426800/000119312526131872/0001193125-26-131872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1426800/000119312526131872/asmb-20260324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-131872
- JSON: https://secwatch.observer/filing/0001193125-26-131872.json
- Plain text: https://secwatch.observer/filing/0001193125-26-131872.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.